Letter

Aspirin and diabetes

Time to rethink aspirin in diabetes?

BMJ 2009; 339 doi: 10.1136/bmj.b5588 (Published 23 December 2009)
Cite this as: BMJ 2009;339:b5588

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Soon H Song, consultant diabetologist1,
  2. Trevor A Gray, consultant chemical pathologist1,
  3. Solomon Tesfaye, consultant diabetologist2
  1. 1Northern General Hospital, Sheffield S5 7AU
  2. 2Royal Hallamshire Hospital, Sheffield S10 2JF
  1. soon_song{at}hotmail.com

    De Berardis and colleagues’ meta-analysis adds to the growing uncertainty about the role of aspirin in preventing cardiovascular disease in diabetes.1

    Despite lack of definitive randomised controlled trial evidence, various guidelines advocate routine use of aspirin on the assumption that diabetic subjects without vascular disease will experience the same clinically …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular